Top

Published in:

01-09-2011

The Effects of Morphine–Neostigmine and Secretin Provocation on Pancreaticobiliary Morphology in Healthy Subjects: A Randomized, Double-blind Crossover Study Using Serial MRCP

Authors: Abeed H. Chowdhury, David J. Humes, Susan E. Pritchard, Luca Marciani, Penny A. Gowland, John Simpson, Dileep N. Lobo

Published in: World Journal of Surgery | Issue 9/2011

Abstract

Background

Secretin-stimulated magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis of sphincter of Oddi dysfunction (SOD), but it does not correlate well with sphincter of Oddi manometry. Serial MRCP following morphine–neostigmine provocation may be of value in the assessment of SOD, but the effects of these pharmacological agents on pancreaticobiliary morphology in healthy subjects have not been studied. The aim of the present study was to use serial MRCP to charactertize the effects of morphine–neostigmine and secretin provocation on serum pancreatic enzyme responses and pancreaticobiliary ductal morphology in healthy subjects.

Methods

Following a baseline scan and serum lipase and amylase assays, 10 healthy subjects were randomized in a double-blind manner to receive morphine (10 mg intramuscularly [IM]), neostigmine (1 mg IM) and saline (intravenously [IV]); OR saline (IM), saline (IM) and secretin (1 U/kg IV). A MRCP study was performed at 5, 30, 60, 90, 120, 150, and 180 min thereafter, with blood samples taken every 60 min for 4 h. Pancreatic duct (PD) diameter, visible PD length, common bile duct (CBD) diameter, and gallbladder volume were recorded. Crossover studies were performed 10 days later.

Results

Serum pancreatic enzyme concentrations were significantly greater (amylase, P = 0.003; lipase, P = 0.04) after morphine–neostigmine than after secretin. Following morphine–neostigmine and secretin provocation, the mean (SEM) percentage increase in PD diameter was 28.7 (7.2) versus 12.9 (3.3); P < 0.0001, and visible PD length was 49.4 (11.5) versus 28.1 (8.2); P < 0.0001, respectively.

Conclusions

The effects of morphine–neostigmine were more pronounced than those of secretin in healthy subjects. The diagnostic utility of morphine–neostigmine stimulated serial MRCP for SOD merits further evaluation.

Goff JS (1988) The human sphincter of Oddi. Physiology and pathophysiology. Arch Intern Med 148:2673–2677PubMedCrossRef

Avisse C, Flament JB, Delattre JF (2000) Ampulla of Vater. Anatomic, embryologic, and surgical aspects. Surg Clin North Am 80:201–212PubMedCrossRef

Bar-Meir S, Halpern Z, Bardan E et al (1984) Frequency of papillary dysfunction among cholecystectomized patients. Hepatology 4:328–330PubMedCrossRef

Anderson TM, Pitt HA, Longmire WP Jr (1985) Experience with sphincteroplasty and sphincterotomy in pancreatobiliary surgery. Ann Surg 201:399–406PubMedCrossRef

Sherman S, Lehman GA (2001) Sphincter of Oddi dysfunction: diagnosis and treatment. JOP 2:382–400PubMed

Bosch A, Pena LR (2007) The sphincter of Oddi. Dig Dis Sci 52:1211–1218PubMedCrossRef

McLoughlin MT, Mitchell RM (2007) Sphincter of Oddi dysfunction and pancreatitis. World J Gastroenterol 13:6333–6343PubMedCrossRef

Geenen JE, Hogan WJ, Dodds WJ et al (1989) The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med 320:82–87PubMedCrossRef

Toouli J, Roberts-Thomson IC, Kellow J et al (2000) Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 46:98–102PubMedCrossRef

10.

Tzovaras G, Rowlands BJ (1998) Diagnosis and treatment of sphincter of Oddi dysfunction. Br J Surg 85:588–595PubMedCrossRef

11.

Chen YK, Foliente RL, Santoro MJ et al (1994) Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 89:327–333PubMed

12.

Sherman S, Ruffolo TA, Hawes RH et al (1991) Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 101:1068–1075PubMed

13.

Wong GS, Teoh N, Dowsett JD et al (2005) Complications of sphincter of Oddi manometry: biliary-like pain versus acute pancreatitis. Scand J Gastroenterol 40:147–153PubMedCrossRef

14.

Lobo DN, Takhar AS, Thaper A et al (2007) The morphine–prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy. Gut 56:1472–1473PubMedCrossRef

15.

LoGiudice JA, Geenen JE, Hogan WJ et al (1979) Efficacy of the morphine–prostigmin test for evaluating patients with suspected papillary stenosis. Dig Dis Sci 24:455–458PubMedCrossRef

16.

Steinberg WM, Salvato RF, Toskes PP (1980) The morphine–prostigmin provocative test—is it useful for making clinical decisions? Gastroenterology 78:728–731PubMed

17.

Barish MA, Yucel EK, Ferrucci JT (1999) Magnetic resonance cholangiopancreatography. N Engl J Med 341:258–264PubMedCrossRef

18.

Mariani A, Curioni S, Zanello A et al (2003) Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 58:847–852PubMedCrossRef

19.

Aisen AM, Sherman S, Jennings SG et al (2008) Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of Oddi dysfunction. Acad Radiol 15:601–609PubMedCrossRef

20.

Pereira SP, Gillams A, Sgouros SN et al (2007) Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 56:809–813PubMedCrossRef

21.

Nardi GL, Acosta JM (1966) Papillitis as a cause of pancreatitis and abdominal pain: role of evocative test, operative pancreatography and histologic evaluation. Ann Surg 164:611–621PubMedCrossRef

22.

Silva AC, Friese JL, Hara AK et al (2004) MR cholangiopancreatography: improved ductal distention with intravenous morphine administration. Radiographics 24:677–687PubMedCrossRef

23.

Kroenke K (2006) Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60:335–339PubMedCrossRef

24.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

25.

Fukukura Y, Fujiyoshi F, Sasaki M et al (2002) Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 222:674–680PubMedCrossRef

26.

Thompson DR (2001) Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol 96:1266–1272PubMedCrossRef

27.

Helm JF, Venu RP, Geenen JE et al (1988) Effects of morphine on the human sphincter of Oddi. Gut 29:1402–1407PubMedCrossRef

28.

Calvey TN (1966) The biliary excretion of neostigmine in the rat. Br J Pharmacol Chemother 28:348–359PubMed

29.

Patney NL, Sharma SK, Singh SP et al (1981) A study of pancreatic enzymes by duodenal intubation in normal subjects after prostigmine administration. Indian J Physiol Pharmacol 25:144–150PubMed

30.

Roberts-Thomson IC, Toouli J (1985) Abnormal responses to morphine–neostigmine in patients with undefined biliary type pain. Gut 26:1367–1372PubMedCrossRef

31.

Igimi H, Yamamoto F, Lee SP (1992) Gallbladder mucosal function: studies in absorption and secretion in humans and in dog gallbladder epithelium. Am J Physiol 263:G69–G74PubMed

Title: The Effects of Morphine–Neostigmine and Secretin Provocation on Pancreaticobiliary Morphology in Healthy Subjects: A Randomized, Double-blind Crossover Study Using Serial MRCP
Authors: Abeed H. Chowdhury
David J. Humes
Susan E. Pritchard
Luca Marciani
Penny A. Gowland
John Simpson
Dileep N. Lobo
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 9/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-011-1162-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Effects of Morphine–Neostigmine and Secretin Provocation on Pancreaticobiliary Morphology in Healthy Subjects: A Randomized, Double-blind Crossover Study Using Serial MRCP

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2011

Learning Curve of Transumbilical Single Incision Laparoscopic Cholecystectomy (SILS): A Preliminary Study of 80 Selected Patients with Benign Gallbladder Diseases

Pancreatic Cancer: The Challenge of the Future in Tumorigenesis-based Prevention

Thoracoscopic Simultaneous Bilateral Bullectomy Through Apicoposterior Transmediastinal Access for Bilateral Spontaneous Pneumothorax: A Challenging Approach

Does Gastric Resection Have a Role in the Management of Severe Postfundoplication Gastric Dysfunction?

The Necessity and Reliability of Intraoperative Parathyroid Hormone (PTH) Testing in Patients with Mild Hyperparathyroidism and PTH Levels in the Normal Range

Osteoprotegerin (OPG) and Related Proteins (RANK, RANKL and TRAIL) in Thyroid Disease